Sign inJoin waitlistJoin the waitlist

JR

Jeffrey Russell

Physician · OneOncology

Credentials: · · · · · · · ·

History

OneOncology
2024–Present

Stanford University
2010–2012
Internal Medicine
University of California School of Medicine
2007–2010
University of Texas School of Medicine at San Antonio
2003–2007

Research

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
The Lancet Oncology · 2016 · 955 citations
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
New England Journal of Medicine · 2022 · 628 citations
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial
JAMA Oncology · 2018 · 313 citations

JC
Jimmy Caudell
8 papers
TP
Tapan Padhya
8 papers
KO
Kristen Otto
7 papers
LH
Louis Harrison
6 papers
TS
Tobin Strom
6 papers · 5 as a resident
Arash Naghavi
5 papers · 5 as a resident
JK
Julie Kish
5 papers
VM
Vincent Miller
5 papers
Jane Messina
4 papers
Jeffrey Ross
4 papers
JM
Judith Mccaffrey
4 papers
SD
Sandra D'Angelo
4 papers

Clinical trials

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2025–2031
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Georgiamune Inc
2024–2027
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Site PI · Recruiting · Phase 1
Compass Therapeutics
2024–2027
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
Site PI · Recruiting · Phase 1, Phase 2
Georgiamune Inc
2023–2026